When medical science and technology come together, the potential to save lives increases. The First Warning System is a non-invasive breast physiology screening system that identifies breast tissue abnormalities in the early stages of development. The early detection of breast cancer gives women an opportunity to have an increased number of treatment options, increasing the survival rate.
The purpose of the First Warning System is not to diagnose, but to serve as a screening mechanism to aid doctors in gathering the data needed to arrive at a diagnosis. The patient would wear the bra over a specified time period and return it to the doctor’s office for analysis. The FWS is non-radiogenic and non-toxic, but what makes it special is that it analyzes dynamic thermal finger print data points (more science here) that can show as much as six years prior to a measurable tumor detected by mammography. Due to the low cost of using one, testing and retesting is more likely to be done when needed.
Like mammograms, the First Warning System is designed to help save lives and I’m interested in seeing how well it will be adopted in the medical industry. First Warning Systems plans to commercialize the BSE bra in Europe in 2013 and, pending FDA approval, in the United States in 2014.